Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 166

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Review article: current management of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis

Open access
YOUNOSSI, Z. M. · 2008 · Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background Non‐alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome. Aim To assess the epidemiological impact and the current management of patients with NAFLD. Methods Published peer‐reviewed literature and abstracts concerning NAFLD and non‐alcoholic steatohepatitis (NASH) were reviewed. Articles specifically related to epidemiology, diagnosis and current treatment strategies for NAFLD and NASH are summarized. Results NAFLD is strongly associated with the epidemic of obesity and type‐2 diabetes mellitus, and is estimated to affect about 20–30% of the population in the US. From the spectrum of NAFLD, only patients with biopsy‐proven NASH (estimated prevalence in the US population is about 3–5%) have been convincingly shown to progress to cirrhosis, liver failure and hepatocellular carcinoma. The clinical manifestation of NAFLD is usually absent or subtle, with abnormal aminotransferases or incidental radiographic findings of fatty liver. The pathogenesis of NAFLD is attributed to a multi‐hit process involving insulin resistance, oxidative stress, apoptotic pathways, and adipocytokines. In 2008, there is no established treatment for NAFLD. Weight loss and treatment for each component of metabolic syndrome. Nevertheless, a large number of agents are being considered in clinical trials of patients with NASH. Conclusions Awareness of the tremendous impact of NAFLD as an important cause of chronic liver disease is increasing along with a great deal of information about its pathogenesis. Future, well‐designed clinical trials that target specific pathways involved in the pathogenesis of NASH are urgently needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2008.03710.x

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 166

Metadata

Authors
YOUNOSSI, Z. M.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2008-06-02
Volume
28
Issue
1
Pages
2-12
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1548087902
Cited by
166
References
16
FWCI
12.26
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Review article: current management of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis. https://app.cochat.ai/papers/10.1111/j.1365-2036.2008.03710.x
The paper
YOUNOSSI, Z. M. (2008). Review article: current management of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2008.03710.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.